Navigation Links
Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
Date:9/17/2009

SAN DIEGO, Sept. 17, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will hold a conference call and webcast presentation on Friday, September 18, 2009, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss top-line results from BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management), the second of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management.

The conference call may be accessed by dialing 888.312.3047 for domestic callers and 719.325.2234 for international callers. Please specify to the operator that you would like to join the "Lorcaserin BLOSSOM Trial Results" conference call. The conference call and slide presentation will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Biosimilars are not generics and the ... and Drug Administration (FDA) for recognizing that each ... guidance issued today. The FDA,s draft guidance on ... calling for biological products to bear a nonproprietary ... reflects the agency,s thinking that "there is a ...
(Date:8/27/2015)... 27, 2015 According to a new market ... Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type ... published by MarketsandMarkets, the Medical Lifting Sling Market is poised to ... 2015, at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
(Date:8/27/2015)... 27, 2015  Now that Intuitive Surgical, Inc.® has ... surgical robot, hospitals with robotic surgery programs need to ... to see where they stand with robotic surgery. Are ... Have they adopted best practices for safety? Should they ... future? ECRI Institute, which has nearly 50 ...
Breaking Medicine Technology:Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... advantage of five major benefits of the new health care law, ... To help you better understand the Affordable Care Act, ... , a web portal that explains what,s changing and when. ... is Mayra Alvarez, Director of Public Health Policy in the Office ...
... 2011 Echo Therapeutics, Inc. (OTCBB: ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, today announced that Christopher P. ... Financial Officer.  Mr. Schnittker is a senior executive ...
Cached Medicine Technology:Five Benefits of the New Health Care Law 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 3
(Date:8/28/2015)... ... August 28, 2015 , ... ... a low cost. Personalized with practice contact information and logos, Calendars stand alone ... can also incorporate Calendars into seasonal mailings, thank you and welcome communications, and ...
(Date:8/28/2015)... ... 28, 2015 , ... Mendon, IL, home of the Adams County Fairgrounds, was ... for a good cause. In its second year, the “Music With A Mission” benefit ... Rehabilitation. The “Mission” of “Music With A Mission” is to raise money to help ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Louis ... information technology innovation to transform quality and efficiency of healthcare delivery worldwide, announced ... de-identified and aggregated before being publicly shared to document progress and inform policy ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... organization, is pleased to welcome TJS Insurance Group as its newest Partner Firm. ... clients guides them and keeps them focused on their goals. Within the past ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs Steering ... MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst of ... files the PSC may receive for corporate employees involved in the production or ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... will run a half-marathon here Monday in his bid to complete ... raise 100,000 pounds for cancer// research. ,"The 'Great World ... Young, 32, plans to run 314.4 miles between Sep 7 and ... of his endeavour. His final run will be at Newcastle upon ...
... to take stock of the growing numbers of people with ... to The Access// Economics report, Asia Pacific Region. ... Asia Pacific region may see a rise in the condition ... region will have to contend with nearly 19.7 million cases, ...
... A national survey has revealed that 26% of teenagers have ... study was conducted by Guideline Inc. on behalf of Liberty ... with drivers' licenses at 26 high schools nationwide. ... during homeroom or study hall to the teens. ...
... surgical ward floor in a Scottish hospital. The patients were ... in Elgin.// ,According to pest control experts, a ... infestation.,NHS Grampian said that the ward was thoroughly cleaned and ... ,An NHS Grampian spokesman said: "There was no ...
... are mere actors, echoed The Bard, eons ago. As the ... crippling disease, today on// World Alzheimer’s day, the stage is set ... its horns and evolve better strategies for effective management of the ... the central nervous system marked by stark and untimely backslide in ...
... Exotic treatments such as a soothing guilt-free chocolate body wrap ... of in post-communist Poland// just a few years ago. ... the growing Polish middle and chattering classes, who seek a ... ,"I received a present to spend a few ...
Cached Medicine News:Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 2Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 3Health News:Luxury Spas Ride Boom in Wellness Industry in Poland 2
... The introduction of the AMO ... in Phaco technology; The combination of ... in complete control of fluidic conditions ... as the "smart Pump" orchestrates the ...
... The Catalyst system introduces a ... precision to microsurgical instrumentation. It ... digital design with advanced microcomputer ... simple to operate with a ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Compact ultrasonic phacoemulsification system....
Medicine Products: